Company Overview of Juvaris BioTherapeutics, Inc.
Juvaris BioTherapeutics, Inc., a biotechnology company, develops adjuvanted vaccines and immunotherapeutics for the treatment of infectious diseases and cancer in the fields of human and animal health. It offers JVRS-100, an adjuvanted vaccine and immunotherapy that provides an adjuvant for prophylactic and therapeutic vaccines against bacterial, viral, and parasitic infections. Juvaris BioTherapeutics, Inc. has a strategic alliance with Bayer HealthCare AG. The company was incorporated in 2001 and is headquartered in Pleasanton, California.
6200 Stoneridge Mall Road
Pleasanton, CA 94588
Founded in 2001
Key Executives for Juvaris BioTherapeutics, Inc.
Similar Private Companies By Industry
|Gencia Corporation||United States|
|OrthoCyte Corporation||United States|
|Kemp Biotechnologies Inc.||United States|
|Mirari Biosciences, Inc.||United States|
|IATRICa, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- New York City, NY | BloombergPosted: Apr 14
- Cambridge, MA | Biogen IdecPosted: Apr 15
- Delaware | DuPontPosted: Apr 11
- San Francisco, CA | Investment Firm Providing Private and Institutional BrokeragePosted: Apr 07
Sponsored Financial Commentaries
To contact Juvaris BioTherapeutics, Inc., please visit www.juvaris.com. Company data is provided by Capital IQ. Please use this form to report any data issues.